急性脑室引流市场按应用、最终用户、产品类型、技术、引流类型、病患年龄层和通路划分－2025-2032年全球预测

预计到 2032 年，急性脑室引流市场规模将达到 5.8444 亿美元，复合年增长率为 10.30%。

主要市场统计数据
基准年 2024	2.6664亿美元
预计年份：2025年	2.9393亿美元
预测年份：2032年	5.8444亿美元
复合年增长率 (%)	10.30%

简要说明了影响现代重症加护。

急性期脑室内引流（EVD）系统仍然是重症加护的基石，在脑脊髓液分流、颅内压监测和急诊神经外科手术中发挥着至关重要的作用。现代临床实务强调对水脑症、蜘蛛网膜下腔出血、创伤性脑损伤和复杂性颅内高压患者进行快速、规范的主导。因此，临床医生和医疗系统必须在临床疗效、感染预防、易用性和工作流程效率之间取得平衡。这些优先事项影响了急性护理机构的采购考量和采购管道。

技术发展和医疗管道的转变正在改变人们对伊波拉病毒疾病（EVD）设备的期望，使其从一次性预包装套件转向更模组化、可重复使用且设计用于永续营运模式的系统。同时，监管机构对设备无菌性、上市后监测和临床结果的审查日益严格，促使製造商加强基于实证医学的包装设计。总而言之，这些动态共同作用，使得临床需求、医院营运限制和监管要求影响设备的设计、分销和应用。

感染控制优先事项、分散式医疗管道以及以整体拥有成本为中心的采购方式如何再形成医疗器材设计和商业化策略

过去几年，医院和专科中心在急性期脑室外引流管的设计、供应和使用方面发生了显着变化。临床上对最大限度减少感染和提高监测准确性的重视，促使人们采用封闭式系统技术和整合压力感测器。同时，医疗服务模式正在将一些神经外科手术分散到门诊手术中心和专科诊所，这改变了需求模式并影响了库存策略。

此外，采购团队越来越关注整体拥有成本，倾向于选择可减少再处理负担的一次性套装，同时也在探索可透过完善的灭菌通讯协定进行最佳化的可重复使用系统。数位健康整合和远端监测正开始出现在相关设备生态系统中，而可追溯性和不利事件报告的法律规范也在不断完善，这促使製造商优先考虑上市后资料收集。这些转变的汇聚迫使现有供应商和新参与企业重新思考其产品蓝图和商业策略，以符合临床医生的偏好和机构的要求。

美国关税结构调整对商业和供应链的影响，以及对製造商和医疗保健系统在2025年需要做出的策略选择的预测

美国关税政策预计将于2025年发生变化，这将对医疗设备（包括急性护理脑室外引流组件和组装）的采购和供应链产生重要影响。关税调整将影响进口原材料和成品的到岸成本，进而可能影响筹资策略、供应商谈判以及国内外工厂之间的产能分配。因此，采购团队和製造商必须评估供应商合约、对冲策略以及可能转嫁给最终用户的成本，同时也要考虑医院的预算限制。

为应对这一局面，製造商可能会加强实现本地化生产，筛选合格的替代供应商，并重新设计产品组件，以减少对受关税影响的零件的依赖。医院和集团采购组织可能会更严格地审查合约条款和库存管理，并要求提高成本驱动因素的透明度。值得注意的是，关税相关的成本压力可能会加速人们对简化物流的一次性组件的需求，或者相反，也可能促使人们重新关注可重复使用的系统，这些系统可以透过资本投资和本地消毒来降低对进口产品的风险。应对这种环境需要商业、监管和供应链团队通力合作，制定应对方案，以在保障临床可用性的同时保护净利率。

一项综合评估揭示了临床适应症、医疗保健环境、产品架构和分销管道如何影响设备设计和销售管道。

细分市场分析揭示了不同临床应用、终端使用者、产品类型、技术、引流方法、患者族群特征和分销模式的驱动因素和采用管道存在差异。在应用领域内，设备设计和临床工作流程直接满足水脑症管理、颅内压监测、蜘蛛网膜下腔出血治疗和创伤性脑损伤管理的需求，每种适应症对监测精度、导管耐用性和感染控制都有独特的要求。对于终端使用者而言，门诊手术中心、医院和专科诊所的手术量、无菌处理能力和采购权限各不相同，这影响了组装一次性套件和集中再处理系统的吸引力。

依产品类型划分，突显了一次性套装和可重复使用系统之间的差异。一次性套装有高配置和标准配置两种选择，当一次性无菌操作和简化的手术流程能够降低感染风险和减少医护人员时间时，它们更具吸引力；而可重复使用系统有多组件和单组件两种形式，当灭菌基础设施和处理能力允许成本摊销时，它们则更受欢迎。封闭式系统通常能够降低污染风险，并符合加护治疗室等临床医生的偏好，而开放式系统在便利性和成本至关重要的情况下仍然适用。将患者年龄分为成人和儿童群体，也会导致导管尺寸、监测阈值和看护者培训等方面的设计差异。最后，分销管道包括分销商、电商平台和医院供应商。分销商包括医疗设备和药品分销商，电商平台则透过製造商网站和第三方平台运营，而医院供应商则透过与医院或集团采购组织签订直接合约进行运营。每个分销管道都需要量身定制的商业性合作策略、合约结构和物流计划，以使产品供应与临床需求相匹配。

区域动态和医疗保健系统差异将决定全球重症加护市场的采用轨迹、监管要求和商业策略。

区域动态正在影响美洲、欧洲、中东和非洲以及亚太地区的医疗设备采用模式、监管预期和竞争强度，每个地区都呈现出独特的机会和挑战。在美洲，先进的重症加护能力、集中的三级神经病学中心以及整合的医院采购框架有利于采用功能丰富的封闭式系统和先进的一次性耗材包，而私人和公共支付方的动态则影响着采购时机和合约结构。过渡期照护模式和对打包支付的重视正促使医疗系统优先选择那些能够降低感染率和缩短住院时间的设备。

在欧洲、中东和非洲，监管协调工作和国家报销政策正在影响市场准入和产品应用。同时，中东和非洲部分地区基础设施的不平衡导致市场对经济实惠的可重复使用系统和易于取得的一次性手术包的需求不断增长。在亚太地区，神经外科手术能力的快速提升、强大的区域製造生态系统以及不断完善的监管管道，为全球供应商和本地製造商都创造了机会。部分市场的价格敏感性，加上都市区三级医疗中心对先进解决方案日益增长的需求，迫使製造商提供差异化的产品系列和灵活的商业模式，以满足当地需求。

竞争格局表明，规模、临床证据和服务整合将决定供应商的差异化和市场定位。

急性脑室外引流器材领域的竞争格局由成熟的医疗技术公司、神经外科器械专家和灵活的利基创新者组成。大型製造商利用其规模、全球分销网络和广泛的临床产品组合来赢得医院合同，并提供包括培训、上市后监测和服务协议在内的复杂提案主张。另一方面，规模较小的专业公司则致力于导管设计、封闭式系统技术和整合监测功能的创新，并经常与临床中心合作，以检验产品性能并加快临床医生的接受度。

目的地设备製造商 (OEM) 与契约製造)之间更深入的合作，能够加快产品迭代速度并优化成本，同时分散供应链风险。如今，策略差异化不仅取决于价格，还取决于临床证据的产生、感染控制能力以及全生命週期服务。此外，通路策略也各不相同，有些供应商强调与医院直接签订合约或参与集团采购组织，而有些供应商则利用经销商网路和数位化管道来扩大覆盖范围。竞争优势取决于临床声明与营运价值的契合度，以及在病患疗效和工作流程效率方面取得的可衡量改善。

製造商和医疗系统可采取的策略重点，以提升神经重症重症加护领域的临床疗效、供应链韧性和差异化商业性执行力。

产业领导者应优先考虑在简化供应链和商业执行流程的同时，保障临床疗效。首先，应投资临床研究和真实世界证据项目，量化感染率、ICU住院时间和器械相关併发症的降低情况，并支持采购谈判和报销协调。其次，应优化产品系列，涵盖一次性高级套件和可重复使用系统，使医疗机构能够选择符合其灭菌能力和成本控制目标的解决方案。在产品优化的同时，应透过双重采购、关键零件近岸外包以及针对关税主导的成本变化製定明确的应急计划，来增强供应链的韧性。

在商业性，我们为门诊手术中心、医院和专科诊所提供灵活的合约条款、培训方案和循证价值命题，并根据最终用户和地区定制合约模式。我们积极采用数位化管道和直接面向製造商的电子商务模式，以支援快速补货并满足分散式临床机构的需求。最后，我们与临床领导者合作，共同製定简化设备设置和维护的通讯协定，从而减少结果差异，并提升高端设备属性的感知价值。

采用严谨的混合方法，结合临床医生的见解、监管审查和情境建模，对设备、临床和供应链动态进行全面且经过验证的检验。

本执行摘要的调查方法融合了定性和定量方法，以确保强有力的依证和平衡的解释。主要资料来源包括对临床负责人、采购专业人员和工程团队的结构化访谈，并辅以典型医疗机构流程的观察分析。次要资料来源则利用同侪审查的临床文献、监管文件、设备标籤和製造商产品规格，以证实技术能力和安全性。

所采用的分析技术包括：跨产品类型的特征比较映射、基于情境的供应链建模（用于评估关税的影响）以及細項分析（用于按应用、最终用户和分销管道识别不同的需求丛集）。在条件允许的情况下，研究结果透过临床专家小组和技术审查进行交叉检验，以确保其实际应用价值。研究还指出了局限性和数据缺口，并建议进行后续研究，以进一步了解长期临床结果和设备生命週期经济性。

整合临床、营运和商业性的必要因素，以确定哪些策略方法能够带来持续的推广应用，并在患者照护取得可衡量的改进。

总之，急性期脑室外引流系统在临床需求、营运要求和商业复杂性之间起着至关重要的作用。儘管临床上对感染控制和监测精准性的重视使得许多医疗机构倾向于使用封闭式系统和精心配置的抛弃式套件，但当消毒基础设施能够支持经济高效的重复使用时，可重复使用系统就显得尤为重要。关税变化和区域采购动态要求积极主动的供应链和商业规划，以确保供应并维持利润结构。

能够将强有力的临床证据与灵活的产品系列、稳健的筹资策略以及有针对性的区域性商业性模式相结合的製造商，将更有能力满足不断变化的临床医生和采购人员的期望。相较之下，医疗系统和采购团队将受益于更清晰的整体拥有成本分析、更严格的通讯协定协调以及对那些能够显着减少併发症和工作流程负担的医疗器材的选择性应用。临床相关人员、製造商和供应链合作伙伴之间的持续协作对于将创新转化为患者照护可衡量的改进至关重要。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 抗菌涂层导管的广泛应用可减少EVD相关感染疾病和併发症。
• 来自无线颅内压监测和脑室外引流系统整合的即时神经重症加护治疗数据
• 为最大限度降低交叉感染风险，对一次性脑室引流管的需求不断增长
• 开发微创导管插入技术以缩短重症重症患者的ICU住院时间
• 扩展支援远端医疗的伊波拉病毒病管理平台，用于远端监测和咨询
• 增加对配备压力感测器和自动引流控制演算法的智慧型脑室外引流系统的投资
• 新型银涂层引流管获监管部门核准用于神经外科手术中对抗多重抗药性病原体
• 设备製造商和人工智慧开发商合作，优化加护治疗中的脑室外引流装置放置和血流通讯协定。

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 按应用分類的急性脑室引流市场

• 水脑症的治疗
• 颅内压监测
• 蜘蛛网膜下腔出血的治疗
• 创伤性脑损伤的治疗

9. 按最终用户分類的急性脑室引流市场

• 门诊手术中心
• 医院
• 专科诊所

第十章 按产品类型分類的急性脑室引流市场

• 免洗工具包
  • 高级套件
  • 标准套件
• 可重复使用系统
  • 多组件系统
  • 单组件系统

第十一章 按技术分類的急性脑室引流市场

• 封闭系统
• 开放系统

第十二章 按引流类型分類的急性脑室引流市场

• 连续排水
• 间歇性排水

第十三章 按病患年龄组别分類的急性脑室引流市场

• 成人
• 孩子们

第十四章 急性脑室引流市场（依通路划分）

• 经销商
  • 医疗设备经销商
  • 药品经销商
• 电子商务
  • 製造商网站
  • 第三方网站
• 医院供应商
  • 与医院直接签订合约
  • 集团采购组织

第十五章 各地区急性脑室引流市场

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十六章 急性脑室引流市场（依组别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十七章 各国急性脑室引流市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十八章 竞争格局

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • Medtronic plc
  • B. Braun Melsungen AG
  • Integra LifeSciences Corporation
  • Smiths Medical, Inc.
  • Teleflex Incorporated
  • Becton, Dickinson and Company
  • Stryker Corporation
  • ICU Medical, Inc.
  • Baxter International Inc.
  • Boston Scientific Corporation

The Acute External Ventricular Drain Market is projected to grow by USD 584.44 million at a CAGR of 10.30% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 266.64 million
Estimated Year [2025]	USD 293.93 million
Forecast Year [2032]	USD 584.44 million
CAGR (%)	10.30%

A concise orientation to the evolving clinical, regulatory, and operational context shaping acute external ventricular drain use across modern neurocritical care settings

Acute external ventricular drain (EVD) systems remain a cornerstone of neurocritical care, playing a critical role in cerebrospinal fluid diversion, intracranial pressure monitoring, and emergency neurosurgery. Recent clinical practice has emphasized rapid, protocol-driven interventions for patients with hydrocephalus, subarachnoid hemorrhage, traumatic brain injury, and complex intracranial hypertension. Consequently, clinicians and healthcare systems are balancing the need for clinical efficacy with infection prevention, ease of use, and workflow efficiency. These priorities have shaped purchasing considerations and procurement pathways across acute care settings.

Technology developments and changing care pathways have begun to alter expectations of EVD devices, from single-use, prepackaged kits to more modular reusable systems designed for sustainable operational models. At the same time, regulatory scrutiny around device sterility, post-market surveillance, and clinical outcomes has intensified, prompting manufacturers to strengthen evidence packages. Taken together, these dynamics create a landscape in which clinical demand, hospital operational constraints, and regulatory imperatives converge to influence device design, distribution, and adoption.

How infection-control priorities, decentralized care pathways, and procurement focus on total cost of ownership are reshaping device design and commercialization strategies

The last several years have witnessed transformative shifts in how acute external ventricular drains are designed, supplied, and used within hospitals and specialty centers. Clinically, there is growing emphasis on minimizing infection and improving monitoring precision, which has driven adoption of closed-system technologies and integrated pressure-sensing capabilities. At the same time, healthcare delivery models are decentralizing certain neurosurgical procedures to ambulatory surgical centers and specialty clinics, altering demand patterns and influencing stocking strategies.

Moreover, procurement teams are increasingly focused on total cost of ownership, favoring disposable kits that reduce reprocessing burdens while also exploring reusable systems that can be optimized through robust sterilization protocols. Digital health integration and remote monitoring are beginning to appear in adjacent device ecosystems, and regulatory frameworks have tightened around traceability and adverse event reporting, prompting manufacturers to prioritize post-market data collection. These converging shifts are prompting incumbent suppliers and new entrants to reassess product roadmaps and commercial strategies to align with clinician preferences and institutional imperatives.

Anticipating the commercial and supply chain consequences of United States tariff realignment and the strategic choices manufacturers and health systems must weigh in 2025

United States tariff policy changes projected for 2025 introduce material considerations across the procurement and supply chain landscape for medical devices, including components and assembled acute external ventricular drains. Tariff adjustments affect the landed cost of imported materials and finished devices, which in turn can influence sourcing strategies, supplier negotiations, and the allocation of manufacturing capacity between domestic and offshore facilities. Procurement teams and manufacturers must therefore evaluate supplier contracts, hedging strategies, and potential price pass-through to end users while remaining mindful of hospital budget constraints.

In response, manufacturers may intensify efforts to localize production, qualify alternative suppliers, or redesign product kits to reduce reliance on tariff-impacted components. Hospitals and group purchasing organizations will likely increase scrutiny of contract terms and inventory practices, seeking greater transparency on cost drivers. Importantly, tariff-related cost pressures can also accelerate interest in disposable kits that simplify logistics, or conversely, renew focus on reusable systems where capital investment and local sterilization can mitigate import exposure. Navigating this environment requires coordinated scenario planning between commercial, regulatory, and supply chain teams to preserve margins while sustaining clinical availability.

A comprehensive segmentation-driven assessment revealing how clinical indications, care settings, product architectures, and distribution channels collectively influence device design and commercial pathways

Segmentation analysis reveals differentiated drivers and adoption pathways across clinical applications, end users, product typologies, technologies, drainage approaches, patient demographics, and distribution modalities. By application, device design and clinical workflows respond directly to needs in hydrocephalus management, intracranial pressure monitoring, subarachnoid hemorrhage treatment, and traumatic brain injury management, with each indication imposing unique requirements for monitoring fidelity, catheter durability, and infection control measures. Regarding end users, ambulatory surgical centers, hospitals, and specialty clinics vary in procedural volume, sterile processing capabilities, and purchasing authority, shaping the appeal of preassembled disposable kits versus systems intended for centralized reprocessing.

Product type segmentation highlights a tension between disposable kits and reusable systems. Disposable kits, which include advanced and standard configurations, appeal where single-use sterility and simplified procedural setup reduce infection risk and staff time, whereas reusable systems, available as multi-component and single-component formats, can be preferable where sterilization infrastructure and throughput support cost amortization. Technology segmentation separates closed systems from open systems; closed systems typically reduce contamination risk and support clinician preference in intensive care environments, while open systems retain relevance where simplicity and cost are paramount. Drainage type stratification into continuous versus intermittent approaches affects drainage hardware and monitoring cadence, and patient age segmentation into adult and pediatric populations drives design differences in catheter size, monitoring thresholds, and caregiver training. Finally, distribution channels encompass distributors, ecommerce, and hospital vendors; distributor categories include medical device and pharmaceutical distributors, ecommerce pathways traverse manufacturer websites and third-party platforms, and hospital vendors operate through direct hospital contracts and group purchasing organizations. Each distribution pathway requires tailored commercial engagement strategies, contractual constructs, and logistics planning to align product availability with clinical demand.

Regional dynamics and healthcare system nuances that determine adoption trajectories, regulatory obligations, and commercial strategies across global neurocritical care markets

Regional dynamics shape adoption patterns, regulatory expectations, and competitive intensity across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting distinct opportunities and constraints. In the Americas, advanced neurocritical care capacity, concentration of tertiary neurological centers, and integrated hospital procurement frameworks favor adoption of feature-rich closed systems and advanced disposable kits, while private and public payor dynamics influence acquisition timing and contract structures. Transitional care models and emphasis on bundled payments prompt health systems to prioritize devices that demonstrate reductions in infection rates and length of stay.

Across Europe, Middle East & Africa, regulatory harmonization efforts and national reimbursement policies influence market entry and adoption. In Western Europe, stringent device regulations and high standards for clinical evidence drive manufacturers to invest in post-market studies and value demonstrations, whereas in parts of the Middle East and Africa, infrastructure variability creates pockets of demand for both cost-effective reusable systems and readily available disposable kits. In the Asia-Pacific region, rapidly expanding neurosurgical capacity, strong local manufacturing ecosystems, and evolving regulatory pathways create opportunities for both global suppliers and regional manufacturers. Price sensitivity in some markets coexists with rising demand for advanced solutions in urban tertiary centers, prompting manufacturers to offer differentiated product tiers and flexible commercial models tailored to regional needs.

Competitive landscape characterization highlighting how scale, clinical evidence, and service integration determine supplier differentiation and market positioning

Competitive dynamics in the acute external ventricular drain space are shaped by a mix of established medtech firms, specialized neurosurgical device companies, and agile niche innovators. Larger manufacturers leverage scale, global distribution networks, and broad clinical portfolios to secure hospital contracts and support complex value propositions that include training, post-market surveillance, and service agreements. Conversely, smaller specialized firms drive innovation around catheter design, closed-system technology, and integrated monitoring features, often partnering with clinical centers to validate performance and accelerate clinician acceptance.

Collaboration between original equipment manufacturers and contract manufacturers has deepened, enabling faster product iterations and cost optimization while also dispersing supply chain risk. Strategic differentiation increasingly relies on clinical evidence generation, infection mitigation features, and lifecycle service offerings rather than on price alone. In addition, channel strategies vary: some suppliers emphasize direct hospital contracts and group purchasing organization participation, while others exploit distributor networks and digital channels to expand reach. Ultimately, competitive positioning depends on the ability to align clinical claims with operational value and to demonstrate measurable improvements in patient outcomes and workflow efficiencies.

Actionable strategic priorities for manufacturers and health systems to fortify clinical outcomes, supply resilience, and differentiated commercial execution in neurocritical care

Industry leaders should prioritize actions that safeguard clinical performance while streamlining supply and commercial execution. First, invest in clinical studies and real-world evidence programs that quantify reductions in infection rates, ICU duration, and device-related complications to support procurement discussions and reimbursement alignment. Second, optimize product portfolios to cover both disposable advanced kits and reusable system options, allowing institutions to select solutions that align with their sterilization capabilities and cost-management objectives. Parallel to product optimization, strengthen supply chain resilience through dual sourcing, nearshoring critical components, and clear contingency planning for tariff-driven cost shifts.

Commercially, tailor engagement models by end user and region, offering flexible contract terms, training packages, and evidence-backed value propositions for ambulatory surgical centers, hospitals, and specialty clinics. Embrace digital channels and manufacturer-owned ecommerce to support rapid replenishment and to capture demand from decentralized care sites. Finally, collaborate with clinical leaders to co-develop protocols that simplify device setup and maintenance, thereby reducing variability in outcomes and enhancing the perceived value of premium device attributes.

A rigorous mixed-methods approach combining clinician insight, regulatory review, and scenario modeling to ensure comprehensive and validated analysis of device, clinical, and supply chain dynamics

The research methodology for this executive summary integrates qualitative and quantitative approaches to ensure a robust evidence base and balanced interpretation. Primary inputs include structured interviews with clinical leaders, procurement professionals, and engineering teams, complemented by observational analysis of procedural workflows in representative care settings. Secondary inputs draw on peer-reviewed clinical literature, regulatory documentation, device labeling, and manufacturer product specifications to substantiate technology capabilities and safety profiles.

Analytical techniques employed include comparative feature mapping across product typologies, scenario-based supply chain modeling to assess tariff impacts, and segmentation analysis to identify distinct demand clusters by application, end user, and distribution channel. Wherever possible, findings were cross-validated through clinician expert panels and technical reviews to ensure practical relevance. Limitations and data gaps were explicitly identified, with recommended follow-up research areas to deepen insight into long-term clinical outcomes and device lifecycle economics.

Synthesis of clinical, operational, and commercial imperatives that determines which strategic approaches will deliver sustained adoption and measurable patient-care improvements

In conclusion, acute external ventricular drain systems occupy a critical intersection of clinical necessity, operational imperatives, and commercial complexity. Clinical emphasis on infection control and monitoring precision is tilting preference toward closed systems and carefully configured disposable kits in many care settings, even as reusable systems retain strategic importance where sterilization infrastructure supports cost-effective reuse. Tariff changes and regional purchasing dynamics require proactive supply chain and commercial planning to sustain availability and preserve margin structures.

Manufacturers that pair strong clinical evidence with flexible product portfolios, resilient sourcing strategies, and targeted regional commercial approaches will be best positioned to meet evolving clinician and purchaser expectations. Health systems and procurement teams, by contrast, will benefit from clearer total cost of ownership analyses, tighter protocol alignment, and selective adoption of devices that demonstrably reduce complications and workflow burden. Continued collaboration between clinical stakeholders, manufacturers, and supply chain partners will be essential to translate innovation into measurable improvements in patient care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Rising adoption of antimicrobial-coated catheters to reduce EVD-related infections and complications
• 5.2. Integration of wireless intracranial pressure monitoring with EVD systems for real-time neurocritical care data
• 5.3. Increasing demand for single-use disposable ventricular drains to minimize cross-contamination risks
• 5.4. Development of minimally invasive catheter insertion techniques to shorten ICU stays in neurocritical patients
• 5.5. Expansion of telemedicine-enabled EVD management platforms for remote monitoring and consultation
• 5.6. Growing investments in smart external ventricular drain systems with pressure sensors and automated drainage control algorithms
• 5.7. Regulatory approvals for novel silver-coated drains targeting multi-drug resistant pathogens in neurosurgical care
• 5.8. Collaborations between device manufacturers and AI developers to optimize EVD placement and flow adjustment protocols in critical care

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Acute External Ventricular Drain Market, by Application

• 8.1. Hydrocephalus Management
• 8.2. Intracranial Pressure Monitoring
• 8.3. Subarachnoid Hemorrhage Treatment
• 8.4. Traumatic Brain Injury Management

9. Acute External Ventricular Drain Market, by End User

• 9.1. Ambulatory Surgical Centers
• 9.2. Hospitals
• 9.3. Specialty Clinics

10. Acute External Ventricular Drain Market, by Product Type

• 10.1. Disposable Kits
  • 10.1.1. Advanced Kits
  • 10.1.2. Standard Kits
• 10.2. Reusable Systems
  • 10.2.1. Multi Component Systems
  • 10.2.2. Single Component Systems

11. Acute External Ventricular Drain Market, by Technology

• 11.1. Closed Systems
• 11.2. Open Systems

12. Acute External Ventricular Drain Market, by Drainage Type

• 12.1. Continuous Drainage
• 12.2. Intermittent Drainage

13. Acute External Ventricular Drain Market, by Patient Age Group

• 13.1. Adult
• 13.2. Pediatric

14. Acute External Ventricular Drain Market, by Distribution Channel

• 14.1. Distributors
  • 14.1.1. Medical Device Distributors
  • 14.1.2. Pharmaceutical Distributors
• 14.2. Ecommerce
  • 14.2.1. Manufacturer Websites
  • 14.2.2. Third Party Websites
• 14.3. Hospital Vendors
  • 14.3.1. Direct Hospital Contracts
  • 14.3.2. Group Purchasing Organizations

15. Acute External Ventricular Drain Market, by Region

• 15.1. Americas
  • 15.1.1. North America
  • 15.1.2. Latin America
• 15.2. Europe, Middle East & Africa
  • 15.2.1. Europe
  • 15.2.2. Middle East
  • 15.2.3. Africa
• 15.3. Asia-Pacific

16. Acute External Ventricular Drain Market, by Group

• 16.1. ASEAN
• 16.2. GCC
• 16.3. European Union
• 16.4. BRICS
• 16.5. G7
• 16.6. NATO

17. Acute External Ventricular Drain Market, by Country

• 17.1. United States
• 17.2. Canada
• 17.3. Mexico
• 17.4. Brazil
• 17.5. United Kingdom
• 17.6. Germany
• 17.7. France
• 17.8. Russia
• 17.9. Italy
• 17.10. Spain
• 17.11. China
• 17.12. India
• 17.13. Japan
• 17.14. Australia
• 17.15. South Korea

18. Competitive Landscape

• 18.1. Market Share Analysis, 2024
• 18.2. FPNV Positioning Matrix, 2024
• 18.3. Competitive Analysis
  • 18.3.1. Medtronic plc
  • 18.3.2. B. Braun Melsungen AG
  • 18.3.3. Integra LifeSciences Corporation
  • 18.3.4. Smiths Medical, Inc.
  • 18.3.5. Teleflex Incorporated
  • 18.3.6. Becton, Dickinson and Company
  • 18.3.7. Stryker Corporation
  • 18.3.8. ICU Medical, Inc.
  • 18.3.9. Baxter International Inc.
  • 18.3.10. Boston Scientific Corporation

LIST OF FIGURES

• FIGURE 1. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2032 (%)
• FIGURE 13. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
• FIGURE 15. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 30. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 31. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 32. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 33. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 34. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HYDROCEPHALUS MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HYDROCEPHALUS MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HYDROCEPHALUS MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HYDROCEPHALUS MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HYDROCEPHALUS MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HYDROCEPHALUS MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE TREATMENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE TREATMENT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADVANCED KITS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADVANCED KITS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADVANCED KITS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADVANCED KITS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADVANCED KITS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADVANCED KITS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STANDARD KITS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STANDARD KITS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STANDARD KITS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STANDARD KITS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STANDARD KITS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STANDARD KITS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MULTI COMPONENT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MULTI COMPONENT SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MULTI COMPONENT SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MULTI COMPONENT SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MULTI COMPONENT SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MULTI COMPONENT SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SINGLE COMPONENT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SINGLE COMPONENT SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SINGLE COMPONENT SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SINGLE COMPONENT SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SINGLE COMPONENT SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SINGLE COMPONENT SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CLOSED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CLOSED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CLOSED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CLOSED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CLOSED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CLOSED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY OPEN SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY OPEN SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY OPEN SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY OPEN SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY OPEN SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY OPEN SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CONTINUOUS DRAINAGE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CONTINUOUS DRAINAGE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CONTINUOUS DRAINAGE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CONTINUOUS DRAINAGE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CONTINUOUS DRAINAGE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CONTINUOUS DRAINAGE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTERMITTENT DRAINAGE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTERMITTENT DRAINAGE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTERMITTENT DRAINAGE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTERMITTENT DRAINAGE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTERMITTENT DRAINAGE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTERMITTENT DRAINAGE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PHARMACEUTICAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PHARMACEUTICAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PHARMACEUTICAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PHARMACEUTICAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PHARMACEUTICAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PHARMACEUTICAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 163. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 164. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 165. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 166. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 167. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 168. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 169. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MANUFACTURER WEBSITES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 170. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MANUFACTURER WEBSITES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 171. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY THIRD PARTY WEBSITES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 172. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY THIRD PARTY WEBSITES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY THIRD PARTY WEBSITES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY THIRD PARTY WEBSITES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 175. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY THIRD PARTY WEBSITES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 176. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY THIRD PARTY WEBSITES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 177. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2024 (USD MILLION)
• TABLE 178. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2025-2032 (USD MILLION)
• TABLE 179. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 180. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 181. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 182. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 183. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 184. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 185. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DIRECT HOSPITAL CONTRACTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 186. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DIRECT HOSPITAL CONTRACTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 187. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DIRECT HOSPITAL CONTRACTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 188. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DIRECT HOSPITAL CONTRACTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 189. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DIRECT HOSPITAL CONTRACTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 190. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DIRECT HOSPITAL CONTRACTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 191. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 192. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 193. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 194. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 195. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 196. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 197. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 198. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 199. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 200. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 201. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 202. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 203. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 204. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 205. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 206. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 207. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2024 (USD MILLION)
• TABLE 208. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2025-2032 (USD MILLION)
• TABLE 209. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 210. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 211. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 212. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 213. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2024 (USD MILLION)
• TABLE 214. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2025-2032 (USD MILLION)
• TABLE 215. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 216. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 217. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 218. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 219. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
• TABLE 220. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
• TABLE 221. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2024 (USD MILLION)
• TABLE 222. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2025-2032 (USD MILLION)
• TABLE 223. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2024 (USD MILLION)
• TABLE 224. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2025-2032 (USD MILLION)
• TABLE 225. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 226. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 227. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 228. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 229. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 230. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 231. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 232. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 233. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2024 (USD MILLION)
• TABLE 234. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2025-2032 (USD MILLION)
• TABLE 235. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 236. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 237. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 238. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 239. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2024 (USD MILLION)
• TABLE 240. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2025-2032 (USD MILLION)
• TABLE 241. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 242. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 243. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 244. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 245. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
• TABLE 246. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
• TABLE 247. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2024 (USD MILLION)
• TABLE 248. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2025-2032 (USD MILLION)
• TABLE 249. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2024 (USD MILLION)
• TABLE 250. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2025-2032 (USD MILLION)
• TABLE 251. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 252. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 253. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 254. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 255. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 256. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 257. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 258. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 259. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2024 (USD MILLION)
• TABLE 260. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2025-2032 (USD MILLION)
• TABLE 261. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 262. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 263. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 264. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 265. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2024 (USD MILLION)
• TABLE 266. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2025-2032 (USD MILLION)
• TABLE 267. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 268. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 269. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 270. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 271. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
• TABLE 272. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
• TABLE 273. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2024 (USD MILLION)
• TABLE 274. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2025-2032 (USD MILLION)
• TABLE 275. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2024 (USD MILLION)
• TABLE 276. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2025-2032 (USD MILLION)
• TABLE 277. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 278. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 279. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 280. EUROPE, MIDDLE